Cargando…
Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
Many animal studies have shown that oral administration of the nicotinamide adenine dinucleotide (NAD(+)) precursor nicotinamide mononucleotide (NMN) prevents the reduction of NAD(+) levels in organs and tissues, helping alleviate aging-related diseases. However, there are very few clinical reports...
Autores principales: | Katayoshi, Takeshi, Uehata, Sachi, Nakashima, Noe, Nakajo, Takahisa, Kitajima, Natsuko, Kageyama, Masakatsu, Tsuji-Naito, Kentaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935856/ https://www.ncbi.nlm.nih.gov/pubmed/36797393 http://dx.doi.org/10.1038/s41598-023-29787-3 |
Ejemplares similares
-
Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain
por: Ramanathan, Chidambaram, et al.
Publicado: (2022) -
Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects
por: Okabe, Keisuke, et al.
Publicado: (2022) -
Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men
por: Igarashi, Masaki, et al.
Publicado: (2022) -
Metabolism and biochemical properties of nicotinamide adenine dinucleotide (NAD) analogs, nicotinamide guanine dinucleotide (NGD) and nicotinamide hypoxanthine dinucleotide (NHD)
por: Yaku, Keisuke, et al.
Publicado: (2019) -
Nicotinamide adenine dinucleotide as a photocatalyst
por: Kim, Jinhyun, et al.
Publicado: (2019)